SQZ Biotechnologies Announces First Autoimmune Disease Indication for Tolerizing Antigen Carrier (TAC) Platform
WATERTOWN, Mass.--(BUSINESS WIRE)--Sep 13, 2021-- |!| Oelwein
WATERTOWN, Mass.--(BUSINESS WIRE)--Sep 13, 2021-- |!| Oelwein